Assessment of diabetic polyneuropathy and autonomic neuropathy using current perception threshold in Korean patients with diabetes mellitus

Diabetes and Metabolism Journal

Volumn 38, Issue 4, 2014, Pages 285-293

  Koo, Bo Kyung ^a   Ohn, Jung Hun ^a,b   Kwak, Soo Heon ^a   Moon, Min Kyong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

Cardiac autonomic neuropathy; Current perception threshold; Diabetic neuropathy

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR AUTONOMIC NEUROPATHY; COMPUTER PROGRAM; CONDUCTOR; CORRELATION ANALYSIS; CURRENT PERCEPTION THRESHOLD; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEART RATE VARIABILITY; HUMAN; INDEX FINGER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE CELL STIMULATION; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHY TOTAL SYMPTOM SCORE; PERCEPTIVE THRESHOLD; PRESSURE SENSATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOUTH KOREAN; TOE;

EID: 84906925114     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2014.38.4.285     Document Type: Article

References (19)

1. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758-65.
2. American Diabetes Association. Standards of medical care in diabetes: 2013. Diabetes Care 2013;36 Suppl 1:S11-66.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.
4. Rendell MS, Dovgan DJ, Bergman TF, O'Donnell GP, Drobny EP, Katims JJ. Mapping diabetic sensory neuropathy by current perception threshold testing. Diabetes Care 1989;12:636-40.
5. Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of the neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994;11:872-6.
6. Cheng WY, Jiang YD, Chuang LM, Huang CN, Heng LT, Wu HP, Tai TY, Lin BJ. Quantitative sensory testing and risk factors of diabetic sensory neuropathy. J Neurol 1999;246:394-8.
7. Nather A, Neo SH, Chionh SB, Liew SC, Sim EY, Chew JL. Assessment of sensory neuropathy in diabetic patients without diabetic foot problems. J Diabetes Complications 2008;22:126-31.
8. Matsutomo R, Takebayashi K, Aso Y. Assessment of peripheral neuropathy using measurement of the current perception threshold with the neurometer in patients with type 2 diabetes mellitus. J Int Med Res 2005;33:442-53.
9. Masson EA, Veves A, Fernando D, Boulton AJ. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989;32:724-8.
10. Bastyr EJ 3rd, Price KL, Bril V; MBBQ Study Group. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 2005;27:1278-94.
11. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
12. Neurotron, Incorporated Innovative Medical Technology: Neurometer® CPT® Painless Electrodiagnostic Clinical and Laboratory Sensory Nerve Testing Equipment. Available from: http://www.neurotron.com/downloads/Professional_Feasibility_Report_Neurology.pdf (updated 2013 Dec 2).
13. Veves A, Young MJ, Manes C, Boulton AJ. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994;17:1200-2.
14. Centers for Disease Control and Prevention: Age-adjusted incidence of end-stage renal disease related to diabetes mellitus (ESRD-DM) per 100,000 diabetic population, by race, ethnicity, and sex, United States, 1980-2008. Available from: http://www.cdc.gov/diabetes/statistics/esrd/fig5.htm (updated 2013 Oct 21).
15. Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients: a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010;8:62.
16. Legrady P, Bajcsi D, Lengyel C, Varkonyi TT, Fejes I, Kempler P, Abraham G. Investigation of cardiac autonomic and peripheral sensory neuropathy in diabetic and nondiabetic patients with hypertension. Clin Exp Hypertens 2013;35:465-9.
17. Keresztes K, Istenes I, Folhoffer A, Lakatos PL, Horvath A, Csak T, Varga P, Kempler P, Szalay F. Autonomic and sensory nerve dysfunction in primary biliary cirrhosis. World J Gastroenterol 2004;10:3039-43.
18. Putz Z, Tabak AG, Toth N, Istenes I, Nemeth N, Gandhi RA, Hermanyi Z, Keresztes K, Jermendy G, Tesfaye S, Kempler P. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009;32:181-3.
19. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-93.